← FDA Drug Approvals (Drugs@FDA)

ANTEPAR

NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 1957-01-25

Drug application

FDA Application #

NDA009102

Application type

New Drug Application

Brand name

ANTEPAR

Generic name

Piperazine Citrate

Active ingredients

PIPERAZINE CITRATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

GLAXOSMITHKLINE

First approval

1957-01-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown